Preparation and characterization of amorphous, i and II forms of clopidogrel hydrogen sulfate

Crystal Research and Technology

Volumn 47, Issue 5, 2012, Pages 505-510

  Lu, Jie ^a   Wang, Jing ^a   Rohani, S ^b  

^a JIANGNAN UNIVERSITY   (China)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

characterization; clopidogrel hydrogen sulphate; polymorphs; transformation

Indexed keywords

CLOPIDOGREL; CRYSTALLIZATION MECHANISMS; HYDROGEN SULFATE; HYDROGEN SULPHATE; OILING OUT; POWDER X-RAY DIFFRACTION (PXRD); REACTIVE CRYSTALLIZATION; TEMPERATURE DEPENDENT; THERMOCHEMICAL DATA; TRANSFORMATION;

CHARACTERIZATION; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; POLYMORPHISM; X RAY DIFFRACTION;

DRUG PRODUCTS;

EID: 84860679517     PISSN: 02321300     EISSN: 15214079     Source Type: Journal    
DOI: 10.1002/crat.201200037     Document Type: Article

References (29)

1. S. L. Morissette, Ö. Almarsson, M. L. Peterson, J. F. Remenar, M. J. Read, A. V. Lemmo, S. Ellis, M. J. Cima, and, C. R. Gardner, Adv. Drug Deliv. Rev. 56, 275 (2004).
2. S. R. Byrn, R. R. Pfeiffer, and, J. G. Stowell, Solid State Chemistry of Drugs (SSCI, West Lafayette, 1999), p. 259.
3. J. K. Haleblian, and, W. J. McCrone, J. Pharm. Sci. 58, 911 (1969).
4. J. Lu, and, S. Rohani, Org. Process Res. Dev. 13, 1262 (2009).
5. G. A. Stephenson, R. A. Forbes, and, S. M. Reutzel-Edens, Adv. Drug Deliv. Rev. 48, 67 (2001).
6. J. Lu, and, S. Rohani, Curr. Med. Chem. 16, 884 (2009).
7. L. Yu, Adv. Drug Deliv. Rev. 48, 27 (2001).
8. A. Grunenberg, J. O. Henck, and, H. W. Siesler, Int. J. Pharm. 129, 147 (1996).
9. J. S. Dickie, and, L. J. Scott, Am. J. Cardiovasc. Drug 6, 407 (2006).
10. A. Badorc, and, D. Fréhel, U.S. Patent 4847265 (1989).
11. R. Lifshitz-Liron, E. Kobalevski-Ishai, S. Wizel, S. Avhar-Maydan, and, R. Lido-Hadas, U.S. Patent Application 20030225129 A1 (2003).
12. L. Song, M. Li, and, J. Gong, J. Chem. Eng. Data 55, 4016 (2010).
13. H. Mao, H. Qian, and, C. Chen, WIPO Patent Application 2005100364 A1 (2005).
14. A. Bousquet, B. Castro, and, J. Saint-Germain, U.S. Patent 6429210 (2002).
15. J. Mukarram, S. Mohammed, M. A. Yekanathsa, and, K. A. Reyaz, WIPO Patent Application 2005012300 A1 (2005).
16. C. Li, CN Patent 101100471 (2008).
17. T. Kozluk, and, R. Wozniak, U.S. Patent Application 20100216999 A1 (2010).
18. B. B. Lohray, V. B. Lohray, B. Pandey, and, M. G. Dave, U.S. Patent Application 20070037842 A1 (2007).
19. H. J. Kim, and, K. J. Kim, J. Pharm. Sci. 97, 4473 (2008).
20. X. Pan, H. Mao, and, X. Lang, Fine Chem. 23, 1221 (2006).
21. H. J. Kim, and, K. J. Kim, Ind. Eng. Chem. Res. 48, 11133 (2009).
22. V. Koradia, G. Chawla, and, A. K. Bansal, Acta Pharm. 54, 193 (2004).
23. J. Bernstein, R. J. Davey, and, J. O. Henck, Angew. Chem. Int. Ed. 38, 3440 (1999).
24. L. Codan, M. U. Bäbler, and, M. Mazzotti, Cryst. Growth Des. 10, 4005 (2010).
25. L. E. O'Brien, P. Timmins, A. C. Williams, and, P. York, J. Pharm. Biomed. Anal. 36, 335 (2004).
26. P. J. Skrdla, V. Antonucci, L. S. Crocker, R. M. Wenslow, L. Wright, and, G. Zhou, J. Pharm. Biomed. Anal. 25, 731 (2001).
27. K. R. Morris, U. J. Griesser, C. J. Eckhardt, and, J. G. Stowell, Adv. Drug Deliv. Rev. 48, 91 (2001).
28. M. Alleso, F. Tian, C. Cornett, and, J. Rantanen, J. Pharm. Sci. 99, 3711 (2010).
29. Y. Sonoda, F. Hirayama, H. Arima, Y. Yamaguchi, W. Saenger, and, K. Uekama, Cryst. Growth Des. 6, 1181 (2006).